Empiric antifungal therapy for the neutropenic patient - The Wingard/Leather article reviewed

被引:0
|
作者
Walsh, TJ [1 ]
Wayne, AS [1 ]
Chanock, SJ [1 ]
Groll, AH [1 ]
机构
[1] NCI, Pediat Oncol Branch, Bethesda, MD 20892 USA
来源
ONCOLOGY-NEW YORK | 2001年 / 15卷 / 03期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:368 / 369
页数:2
相关论文
共 50 条
  • [31] Empiric Antifungal Therapy in Patients with Febrile Neutropenia
    Ferrara, Jenna J.
    MacDougall, Conan
    Gallagher, Jason C.
    PHARMACOTHERAPY, 2011, 31 (04): : 369 - 385
  • [32] AMIKACIN AND TICARCILLIN AS EMPIRIC THERAPY IN FEBRILE NEUTROPENIC CHILDREN WITH CANCER
    DESHPANDE, GN
    FADEN, HS
    GROSSI, M
    FREEMAN, AI
    ETTINGER, LJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 387 - 387
  • [33] PROPHYLAXIS AND EMPIRIC THERAPY FOR STREPTOCOCCAL INFECTIONS IN FEBRILE NEUTROPENIC PATIENTS
    VIOT, M
    KLASTERSKY, J
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (07) : 818 - 819
  • [34] EMPIRIC THERAPY IN THE MANAGEMENT OF FEBRILE NEUTROPENIC CANCER-PATIENTS
    ERKISI, MK
    KOKSAL, F
    AKAN, E
    BURGUT, R
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1993, 53 (01): : 23 - 28
  • [35] Preemptive antifungal therapy among neutropenic patients
    Stefani, PM
    Gottardi, M
    Zanetti, F
    Tecchio, C
    Sartor, D
    Gherlinzoni, F
    CLINICAL INFECTIOUS DISEASES, 2006, 42 (10) : 1507 - 1508
  • [36] Prase III randomized trial of nyotran (liposomal, nystatin) or amphotericin B for the empiric antifungal therapy in febrile neutropenic patients.
    Powles, R
    Kulkarni, S
    Treleaven, J
    Hobbs, K
    Sirohi, B
    Bhagwati, N
    Mehta, J
    Singhal, S
    Williams, T
    BLOOD, 1999, 94 (10) : 342A - 342A
  • [37] Empiric antifungal therapy in patients with cutaneous and subcutaneous phaeohyphomycosis
    Noguchi, Hiromitsu
    Matsumoto, Tadahiko
    Kimura, Utako
    Hiruma, Masataro
    Kano, Rui
    Yaguchi, Takashi
    Kubo, Masahide
    Kashiwada-Nakamura, Kayo
    Fukushima, Satoshi
    JOURNAL OF DERMATOLOGY, 2022, 49 (05): : 564 - 571
  • [38] EFFICACY OF TIMENTIN-TOBRAMYCIN AS EMPIRIC THERAPY IN 51 NEUTROPENIC PATIENTS
    BERNHART, M
    KRIEGER, O
    LINEMAYR, G
    LUTZ, D
    BLUT, 1985, 51 (03): : 183 - 183
  • [39] Cefepime versus ceftazidime as empiric therapy for fever in neutropenic patients with cancer
    Chandrasekar, PH
    Arnow, PM
    ANNALS OF PHARMACOTHERAPY, 2000, 34 (09) : 989 - 995
  • [40] EFFICACY OF AMIKACIN AND TICARCILLIN AS EMPIRIC THERAPY IN FEBRILE NEUTROPENIC CHILDREN WITH CANCER
    DESHPANDE, G
    FADEN, H
    SURGALLA, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 333 - 333